Table 5.
Day | Tissue | IFN-α | IFN-γ | IL-1α | IL-1β | IL-6 | IL-8 | IL-10 | IL-12α | IL-12 β | TNF-α | TGF-β |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | Jejunum | < * | < * | < ^ | < ^ | < * | < ^ | |||||
Ileum | ||||||||||||
Colon | < ^ | < ^ | ||||||||||
PBMC | > * | > * | > ^ | > * | > ^ | > * | > * | > * | > ^ | > * | ||
30 | Jejunum | > ^ | < ^ | |||||||||
Ileum | < ^ | |||||||||||
Colon | > * | > ^ | ||||||||||
PBMC | > ^ | |||||||||||
45 | Jejunum | < * | < * | < * | ||||||||
Ileum | > * | |||||||||||
Colon | < ^ | < * | < ^ | |||||||||
PBMC | < * |
(*) Significant (P < 0.05) and (^) tendency (P < 0.1) upregulation ( >) or downregulation ( <) of cytokine mRNA levels of FS compared to control
1Dietary treatment = additional Fysal Solute (FS) at 2 kg/ton